UREAPLASMA-UREALYTICUM CERVICAL COLONIZATION AS A MARKER FOR PREGNANCY COMPLICATIONS

被引:22
作者
HOROWITZ, S
HOROWITZ, J
MAZOR, M
PORATH, A
GLEZERMAN, M
机构
[1] SOROKA MED CTR KUPAT HOLIM,DEPT MED A,BEER SHEVA,ISRAEL
[2] BEN GURION UNIV NEGEV,FAC HLTH SCI,DEPT EPIDEMIOL,IL-84105 BEER SHEVA,ISRAEL
[3] SOROKA MED CTR KUPAT HOLIM,DEPT OBSTET & GYNECOL,BEER SHEVA,ISRAEL
关键词
UREAPLASMA UREALYTICUM; CERVIX; ANTIBODIES TO UREAPLASMA; PREGNANCY OUTCOME;
D O I
10.1016/0020-7292(94)02236-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To determine the clinical significance of cervical colonization with (Ureaplasma urealyticum (Uu) and its possible relationship to pregnancy outcome. Methods: Cervical cultures for Uu and serum antibodies to Uu were determined in four groups of pregnant women: (1) 117 women who underwent mid-trimester amniocentesis; (2) 47 women with preterm labor and intact membranes; (3) 34 women with preterm premature rupture of membranes; and (4) a control group of 315 healthy women with normal pregnancies. Statistical methods used were the chi-square and Fisher's exact tests. Results: A significant increase in the cervical colonization rate with Uu was detected in all study groups (62%, 77% and 74%, respectively) when compared with the control group (42%). Women at mid-trimester of pregnancy with a positive cervical culture and high levels of antibodies, had a higher rate of pregnancy complications than those with a negative culture and absence of antibodies (62 vs. 28%, respectively; P = 0.0006). Conclusion: Cervical colonization with Uu when associated with elevated titers of antibodies to Uu, may serve as a marker for the identification of a subpopulation of women who are at high risk for the development of pregnancy complications.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 25 条
  • [1] CAREY JC, 1991, AM J OBSTET GYNECOL, V164, P728
  • [2] UREAPLASMA-UREALYTICUM INTRAUTERINE INFECTION - ROLE IN PREMATURITY AND DISEASE IN NEWBORNS
    CASSELL, GH
    WAITES, KB
    WATSON, HL
    CROUSE, DT
    HARASAWA, R
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (01) : 69 - 87
  • [3] A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ERYTHROMYCIN FOR THE TREATMENT OF UREAPLASMA-UREALYTICUM TO PREVENT PREMATURE DELIVERY
    ESCHENBACH, DA
    NUGENT, RP
    RAO, AV
    COTCH, MF
    GIBBS, RS
    LIPSCOMB, KA
    MARTIN, DH
    PASTOREK, JG
    RETTIG, PJ
    CAREY, JC
    REGAN, JA
    GEROMANOS, KL
    LEE, MLF
    POOLE, WK
    EDELMAN, R
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (03) : 734 - 742
  • [4] UREAPLASMA-UREALYTICUM AND PREMATURE BIRTH
    ESCHENBACH, DA
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 : S100 - S106
  • [5] ADVERSE OUTCOME IN PREGNANCY FOLLOWING AMNIOTIC-FLUID ISOLATION OF UREAPLASMA-UREALYTICUM
    GRAY, DJ
    ROBINSON, HB
    MALONE, J
    THOMSON, RB
    [J]. PRENATAL DIAGNOSIS, 1992, 12 (02) : 111 - 117
  • [6] ERYTHROMYCIN
    GRIBBLE, MJ
    CHOW, AW
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (01) : 79 - 89
  • [7] A CASE-CONTROL STUDY OF CHORIOAMNIONIC INFECTION AND HISTOLOGIC CHORIOAMNIONITIS IN PREMATURITY
    HILLIER, SL
    MARTIUS, J
    KROHN, M
    KIVIAT, N
    HOLMES, KK
    ESCHENBACH, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (15) : 972 - 978
  • [8] RESPIRATORY-TRACT COLONIZATION WITH UREAPLASMA-UREALYTICUM AND BRONCHOPULMONARY DYSPLASIA IN NEONATES IN SOUTHERN ISRAEL
    HOROWITZ, S
    LANDAU, D
    SHINWELL, ES
    ZMORA, E
    DAGAN, R
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (10) : 847 - 851
  • [9] HOROWITZ S, 1994, ISRAEL J MED SCI, V30, P450
  • [10] ISOLATION AND PURIFICATION OF VIABLE UREAPLASMA-UREALYTICUM CELLS FREE FROM MEDIUM COMPONENTS
    HOROWITZ, S
    GAL, H
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1991, 137 : 1087 - 1092